tirzepatide off the market is fda taking the are they Friendly Reminder 💡 only FDA‑approved U.S. brands FDA Closes the 503B Bulks – FDA says the tirzepatide weight-loss

Then in May 2025, the first direct head-to-head trial SURMOUNT-5 was published in the New England Journal of Medicine , putting the two medications head-to-head in the same patients, at the same time, under the same conditions

This can include the use of GLP-1 medications, which have been shown to promote weight loss and offer additional health benefits such as reduced inflammation, improved glucose control for those with type 2 diabetes, and reduced cardiovascular risk factors

Source: Malaguarnera, Mariano, et al

Your healthcare team can provide personalised advice on managing your treatment regimen safely and effectively

Week 12+: Continued weight loss, potential dose adjustments, focus on long-term maintenance

Typically, a Myers cocktail IV treatment costs between $150 and $250